<DOC>
	<DOCNO>NCT01423552</DOCNO>
	<brief_summary>The ongoing success transplantation largely due development drug stop patient 's body reject new organ . In addition steroid , two main type drug use suppress immune system follow heart transplantation : calcineurin inhibitor ( Ciclosporin-A Tacrolimus ) mycophenolate . However , different patient respond different way drug , dose lead different level drug blood . This varies due genetic factor age , kidney function use drug . Therefore , level immunosuppressive drug blood routinely measure dose adjusted accordingly . However , patient still experience episode rejection despite apparently acceptable level . In study , investigator measure level drug ( blood , type white blood cell call T-cells heart muscle ) effectiveness drug T-cells . The investigator compare level patient genetic factor amount rejection measure heart biopsy . This enable u good understand blood tissue level drug change genetic factor order optimise immunosuppressive therapy improve outcome heart transplantation .</brief_summary>
	<brief_title>Pharmacology Immunosuppressants Following Heart Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>All patient undergoing heart transplantation Decline participation Previous transplantation another organ already receive chronic immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Heart transplantation</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>